LA
MLAB icon

Lindenwold Advisors’s Mesa Laboratories MLAB Stock Holding History

Lindenwold Advisors’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-903
Closed -$230K – 115
2022
Q1 		$230K Buy
903
+50
+6% +$13.6K 0.14% 110
2021
Q4 		$280K Buy
+853
New +$268K 0.16% 105

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Lindenwold Advisors's MLAB Position: Q2 2022 in Review

Lindenwold Advisors sold out of Mesa Laboratories (MLAB) in Q2 2022, closing a stake of 903 shares — an estimated $230K sold.

Lindenwold Advisors first reported a position in MLAB in Q4 2021 and held it in 2 quarters. The position peaked at $280K in Q4 2021. 175 funds tracked by Wall St. Rank hold MLAB as of Q2 2022.

  • Lindenwold Advisors reported no remaining Mesa Laboratories position as of Q2 2022 after selling out during the quarter.
  • Lindenwold Advisors sold 903 Mesa Laboratories shares in Q2 2022, an estimated $230K.
  • Lindenwold Advisors first reported a position in Mesa Laboratories in Q4 2021 and held it in 2 quarters.
  • Lindenwold Advisors's Mesa Laboratories position peaked at $280K in Q4 2021.
  • 175 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2022.

Based on Lindenwold Advisors's 13F filing for Q2 2022, filed 5 Aug 2022.